Skip to Main Content

Once again, Massachusetts is trying to find a way to lower its Medicaid prescription drug bill, but this time, state officials hope to negotiate supplemental rebates — and potentially cite drug makers for violating consumer protection laws if they fail to play ball.

The effort is the latest by state lawmakers to find a way to constrain drug spending, an issue that is stretching budgets across the U.S. amid rising prices, especially for some newer medicines. The move also comes after Massachusetts officials last year failed to win federal government approval to exclude some drugs from the state Medicaid program, which was an earlier attempt to reduce costs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!